Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Urinary proteome profiling using microfluidic technology on a chip.

Visith Thongboonkerd1, Napat Songtawee, Suchai Sritippayawan

  • 1Medical Molecular Biology Unit, Office for Research and Development, Division of Nephrology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand. thongboonkerd@dr.com

Journal of Proteome Research
|April 14, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deciphering Physicochemical Properties of Urinary Proteins from Stone Formers as Macromolecular Prolithogenic Factors to Drive Calcium Oxalate Stone Development.

ACS omega·2026
Same author

Unveiling potential natural promoters of calcium oxalate kidney stones in the urine via anion-exchange chromatography, crystal assays, and proteomics.

Molecular and cellular biochemistry·2026
Same author

Lactobacillus acidophilus abolishes oxalate-mediated renal epithelial barrier disruption and calcium oxalate monohydrate crystal adhesion to renal epithelial cells.

Cellular & molecular biology letters·2026
Same author

Epigallocatechin-3-gallate, l-theanine and theophylline abolish high-glucose-induced renal cell senescence and subsequent epithelial-mesenchymal transition and fibroblast activation via SIRT1/PGC-1α axis: Implications for diabetic kidney disease.

Chemico-biological interactions·2026
Same author

Chlorogenic acid mitigates calcium oxalate monohydrate crystal-induced epithelial-to-mesenchymal transition in renal epithelial cells via suppression of HSP60 expression and p38 signaling.

Cellular & molecular biology letters·2026
Same author

Neutrophil Secretory Proteins Inhibit Calcium Oxalate Crystallisation and Crystal Growth, but Promote Crystal Aggregation.

Immunology·2026

Microfluidic chip technology enables urinary proteome profiling for clinical diagnostics. This method differentiates normal urine from diabetic nephropathy (DN) and IgA nephropathy (IgAN) by analyzing protein spectra, aiding biomarker discovery.

Area of Science:

  • Clinical proteomics and diagnostics
  • Biomarker discovery using microfluidic technology

Background:

  • Clinical proteomics focuses on diagnostics and biomarker discovery.
  • Urinary proteome profiling offers a non-invasive approach for disease detection.

Purpose of the Study:

  • To apply microfluidic chip technology for urinary proteome profiling.
  • To investigate the potential of this technology for differentiating normal, diabetic nephropathy (DN), and IgA nephropathy (IgAN) urine samples.

Main Methods:

  • Utilized microfluidic chip technology for automated protein/peptide separation from small urine volumes (4 microL).
  • Analyzed proteome profiles of 31 healthy individuals, 6 DN patients, and 4 IgAN patients.
  • Employed ANOVA with Tukey post-hoc multiple comparisons to identify significant spectral differences.

Related Experiment Videos

Main Results:

  • Significantly different protein spectra (9 spectra) were observed between normal and DN urine.
  • Three distinct spectra (12-15, 27-28, 34-35 kDa) differentiated DN from IgAN urine.
  • Spectral frequencies could distinguish diseased from normal urine but not between DN and IgAN; no sex-based differences were found.

Conclusions:

  • Microfluidic chip technology is effective for urinary proteome profiling.
  • This approach shows potential for clinical diagnostics and biomarker discovery in kidney diseases.
  • The technology provides a sensitive method for identifying distinct urinary proteomic signatures.